ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Chemed Corporation

Chemed Corporation (CHE)

441,59
9,25
(2,14%)
Geschlossen 08 Juni 10:00PM
441,59
0,00
(0,00%)
Nach Börsenschluss: 1:59AM

Chemed Corporation (CHE) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-05-29Mr. George J. WalshIndependent Chairman-500,00218,92kVerkauf437,833,64k-12,07%
2026-05-08Mr. Patrick P. GraceIndependent Director-60,0025,55kVerkauf425,783,34k-1,77%
2026-05-01Mr. Kevin J. McNamaraCEO, President & Director-2,00k842,26kVerkauf421,1390,22k-2,17%
2026-03-27Mr. Kevin J. McNamaraCEO, President & Director-1,50k554,06kVerkauf369,3792,22k-1,60%
2026-03-12Mr. Kevin J. McNamaraCEO, President & Director-2,00k806,36kVerkauf403,1893,72k-2,09%
2026-02-13Mr. Spencer S. LeeExec. VP345,00162,00kDerivative Exercise and Retained Stock469,5614,91k2,37%
2026-02-13Mr. Spencer S. LeeExec. VP-154,000,00Derivative Exercise and Sale469,5614,91k-
2026-02-13Mr. Thomas C. HuttonVP & Director127,0059,63kDerivative Exercise and Retained Stock469,5679,96k0,16%
2026-02-13Mr. Thomas C. HuttonVP & Director-72,000,00Derivative Exercise and Sale469,5679,96k-
2026-02-13Mr. Joel L. WherleyExec. VP and President & CEO of VITAS Healthcare193,0090,63kDerivative Exercise and Retained Stock469,56852,0029,29%
2026-02-13Mr. Joel L. WherleyExec. VP and President & CEO of VITAS Healthcare-80,000,00Derivative Exercise and Sale469,56852,00-
2026-02-13Mr. Michael D. WitzemanExec. VP, Controller, Principal Accounting Officer & CFO293,00137,58kDerivative Exercise and Retained Stock469,565,95k5,18%
2026-02-13Mr. Michael D. WitzemanExec. VP, Controller, Principal Accounting Officer & CFO-120,000,00Derivative Exercise and Sale469,565,95k-
2026-02-13Mr. Kevin J. McNamaraCEO, President & Director1,52k714,67kDerivative Exercise and Retained Stock469,5695,72k1,62%
2026-02-13Mr. Kevin J. McNamaraCEO, President & Director-1,19k0,00Derivative Exercise and Sale469,5695,72k-
2026-02-13Mr. Brian C. JudkinsVP, Secretary & Chief Legal Officer249,00116,92kDerivative Exercise and Retained Stock469,562,44k11,39%
2026-02-13Mr. Brian C. JudkinsVP, Secretary & Chief Legal Officer-102,000,00Derivative Exercise and Sale469,562,44k-
2025-12-26Dr. Andrea R. LindellIndependent Director-463,000,00Other Disposition-5,54k-7,71%
2025-11-24Mr. Kevin J. McNamaraCEO, President & Director-2,00k875,10kVerkauf437,5594,20k-2,08%
2025-11-19Mr. Spencer S. LeeExec. VP-60,000,00Other Disposition-14,57k-0,41%
2025-09-26Mr. Kevin J. McNamaraCEO, President & Director-3,00k1,38MVerkauf461,2896,20k-3,02%
2025-09-09Mr. Patrick P. GraceIndependent Director-150,0069,51kVerkauf463,393,40k-4,23%
2025-08-05Mr. Kevin J. McNamaraCEO, President & Director-2,00k857,10kVerkauf428,5599,20k-1,98%
2025-08-04Mr. George J. WalshIndependent Chairman200,0083,42kKauf417,103,96k5,32%
2025-08-04Mr. Nicholas Michael WestfallInsider-10,01k4,22MVerkauf421,910,00-100,00%